Montelukast & Levocetirizine Tablets IP are a highly effective combination medication used to manage allergic rhinitis and asthma symptoms. Montelukast, a leukotriene receptor antagonist, helps in preventing bronchoconstriction, while Levocetirizine, an antihistamine, reduces allergy symptoms like sneezing, runny nose, and itching. For pharmaceutical marketers in India, marketing Montelukast & Levocetirizine Tablets IP offers a significant opportunity to cater to the growing demand for allergy and asthma relief medications.
We offer Montelukast & Levocetirizine Tablets IP in various dosages and formulations, catering to diverse therapeutic needs. Each product is the result of rigorous research and development, ensuring optimal bioavailability, minimal side effects, and maximum patient compliance.
Here are the formulations that we have readily available:
Composition | Dosage Form |
MONTELUKAST SODIUM & LEVOCETIRIZINE HCl TABLETS (10+5mg) | Tablets |
MONTELUKAST SODIUM & LEVOCETIRIZINE HCl DISPERSIBLE TABLETS (5+2.5mg) | Tablets |
MONTELUKAST SODIUM & LEVOCETIRIZINE HCl ORAL LIQUID (5+2.5mg/5ml) | Syrup |
MONTELUKAST SODIUM & LEVOCETIRIZINE HCl TABLETS IP (10+5mg) | Tablets |
For businesses looking to source Montelukast & Levocetirizine Tablets IP , partnering with a reputable manufacturer in India is a strategic move. Leading companies like us not only comply with WHO-GMP but also provide comprehensive support from documentation to delivery, ensuring a seamless procurement process.
Apart from these, if you are interested in customizing formulations for your product, we will be glad to be your partner in the journey. We have an in-house formulation development team that will assist you in your journey from development to finished product.
If you are looking for a pharmaceutical manufacturer, consider speaking with us, we have over 30 years of experience, and our product range expands into 60 therapies and over 400 formulations in various forms- tablets, liquids, capsules, externals etc.
Comments